maintains a teaching appointment at the University of Kansas School of Medicine. Dr. Azarnoff is on the editorial board of several journals and has been on committees within the U.S. Food and Drug Administration, World Health Organization, American Medical Association, National Academy of Sciences, Institute of Medicine, and National Institutes of Health, advising them on drags and drag development.

BYRON WM. BROWN, JR., is Professor and Head of the Division of Biostatistics in the Department of Health Research and Policy, School of Medicine, Stanford University. He received a Ph.D. degree in 1959 in biostatistics from the University of Minnesota, where he served on the faculty from 1959 to 1968. Leaving the position there as Division Chief in Biometry to join the faculty at Stanford University, he has served as Division Head of Biostatistics since 1968 and served as Chairman of the Department of Health Research and Policy from 1988 to 1996. His special interests are in the design and analysis of clinical trials, in biological assay statistical methodology, and in the role and methodology of statistics in health enhancement and health policy. He has served on the Veterans Administration Cooperative Studies Evaluation Committee and the Clinical Cancer Investigations Review Committee and as a consultant to the Federal Trade Commission, the U.S. Food and Drug Administration, the INCAP, numerous clinical trial advisory boards and review committees, and government and private industry. He is Past President of the Society for Controlled Clinical Trials and the Western Region of the Biometrics Society and a Fellow of the American Statistical Association and the American Heart Association. He is an elected member of the Institute of Medicine and the International Institute of Statistics.

ROBERT CANCRO obtained his M.D. degree in 1955 from State University of New York, Downstate Medical Center, and his Doctor of Medical Science degree in 1962 from the same institution. His more recent academic activities have involved serving as Professor and Chair of the Department of Psychiatry at the New York University Medical Center since 1976. He is Director of the Nathan Kline Institute for Psychiatric Research, which is a New York State-funded research institute. His major professional interest has been at the brain-behavior interface in psychoses and in particular the schizophrenic disorders. This interest has led to a deep involvement with psychoactive medications, including their use and misuse.

ROBERT D. GIBBONS received his Ph.D. from the University of Chicago in 1981. He is currently a Professor of Biostatistics at the University of Illinois at Chicago. In 1985 he received a Young Scientist Award from the Office of Naval Research, which funded his statistical research in the areas of the analysis of multivariate binary data and the analysis of longitudinal data. Dr. Gibbons has also received additional grant support from the National Institutes of Health and the John D. and Catherine T. MacArthur Foundation. He currently has a Research Scientist Award from the National Institutes of Health that provides full-time. support for statistical research. Applications of Dr. Gibbons work are widespread in the general areas of mental health and environmental sciences. Dr. Gibbons has authored more than 100 peer-reviewed scientific papers and two books. He is currently working on a new book entitled Statistical Methods for Detection and Quantification of Environmental Contamination, which will be published by John Wiley & Sons.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement